| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 39.74▲ | 39.74▲ | 39.70▲ | 39.75▲ | 39.47▲ |
| MA10 | 39.83▲ | 39.84▲ | 39.81▲ | 39.88▲ | 39.84▲ |
| MA20 | 39.93▲ | 39.87▲ | 39.70▲ | 39.52▲ | 39.90▲ |
| MA50 | 39.03▲ | 38.97▲ | 39.03▲ | 40.12▼ | 38.96▲ |
| MA100 | 39.34▲ | 39.77▲ | 39.91▲ | 39.83▲ | 37.15▲ |
| MA200 | 39.95▲ | 39.56▲ | 39.27▲ | 39.20▲ | 33.36▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.054▼ | -0.044▼ | -0.043▼ | 0.042▲ | -0.136▼ |
| RSI | 56.558▲ | 56.875▲ | 57.281▲ | 53.711▲ | 53.023▲ |
| STOCH | 35.587 | 37.634 | 25.067 | 25.208 | 33.168 |
| WILL %R | -13.846▲ | -40.426 | -46.667 | -47.664 | -51.351 |
| CCI | 58.151 | 26.427 | 10.970 | 16.391 | -29.185 |
|
Friday, April 17, 2026 01:57 PM
New phase 2 data from personalized cancer vaccine EVX-01 demonstrates a record-high rate of vaccine targets triggering a tumor-specific immune responseThe results reinforce that Evaxion’s pioneering ...
|
|
Tuesday, April 07, 2026 05:00 AM
Trial extension completed as planned with three-year clinical efficacy data expected to be presented in the second half of 2026The trial has already yielded encouraging one- and two-year data ...
|
|
Tuesday, March 17, 2026 01:30 PM
Two abstracts accepted for presentation One abstract on new additional biomarker and immunogenicity data for personalized cancer vaccine EVX-01 Another abstract on the use of Evaxion’s AI-Immunology™ ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/04/26 | 40.06 | 40.06 | 39.97 | 39.97 | 14,539 |
| 22/04/26 | 39.86 | 39.86 | 39.41 | 39.5115 | 1,660 |
| 21/04/26 | 39.90 | 40.009 | 39.5144 | 39.5144 | 9,143 |
| 20/04/26 | 39.82 | 39.99 | 39.82 | 39.8816 | 4,573 |
| 17/04/26 | 39.88 | 39.92 | 39.74 | 39.8639 | 1,634 |
| 16/04/26 | 40.08 | 40.13 | 39.63 | 39.63 | 5,227 |
| 15/04/26 | 40.15 | 40.15 | 39.74 | 39.76 | 13,740 |
| 14/04/26 | 40.36 | 40.36 | 40.20 | 40.2501 | 2,816 |
| 13/04/26 | 39.91 | 40.24 | 39.80 | 40.24 | 7,819 |
| 10/04/26 | 40.42 | 40.42 | 40.06 | 40.17 | 3,840 |
|
|
||||
|
|
||||
|
|